Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) shares saw an uptick in trading volume on Tuesday . 155,981 shares were traded during trading, a decline of 10% from the previous session’s volume of 172,754 shares.The stock last traded at $5.51 and had previously closed at $5.44.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on AVAH shares. Deutsche Bank Aktiengesellschaft boosted their price target on Aveanna Healthcare from $3.00 to $5.00 and gave the company a “buy” rating in a research report on Friday, August 9th. UBS Group upped their target price on shares of Aveanna Healthcare from $1.70 to $2.80 and gave the company a “sell” rating in a research note on Friday, August 9th. Finally, Royal Bank of Canada lifted their price objective on Aveanna Healthcare from $3.00 to $5.00 and gave the stock a “sector perform” rating in a report on Friday, August 9th.
Read Our Latest Research Report on AVAH
Aveanna Healthcare Stock Up 2.0 %
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last posted its earnings results on Thursday, August 8th. The company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.03. The company had revenue of $504.96 million during the quarter, compared to analyst estimates of $494.02 million. Equities analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.09 EPS for the current year.
Hedge Funds Weigh In On Aveanna Healthcare
Institutional investors have recently bought and sold shares of the business. Acadian Asset Management LLC boosted its stake in Aveanna Healthcare by 185.6% in the first quarter. Acadian Asset Management LLC now owns 29,385 shares of the company’s stock valued at $72,000 after acquiring an additional 19,096 shares during the last quarter. Mackenzie Financial Corp lifted its stake in shares of Aveanna Healthcare by 35.9% in the 2nd quarter. Mackenzie Financial Corp now owns 45,674 shares of the company’s stock valued at $126,000 after purchasing an additional 12,075 shares during the period. Bank of New York Mellon Corp boosted its position in shares of Aveanna Healthcare by 6.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company’s stock worth $413,000 after purchasing an additional 9,243 shares during the last quarter. Renaissance Technologies LLC grew its stake in shares of Aveanna Healthcare by 155.8% during the second quarter. Renaissance Technologies LLC now owns 158,600 shares of the company’s stock worth $438,000 after purchasing an additional 96,600 shares during the period. Finally, Vanguard Group Inc. increased its holdings in Aveanna Healthcare by 1.8% in the first quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock valued at $6,402,000 after purchasing an additional 44,970 shares during the last quarter. Institutional investors own 87.96% of the company’s stock.
About Aveanna Healthcare
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Read More
- Five stocks we like better than Aveanna Healthcare
- What is the FTSE 100 index?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Conference Calls and Individual Investors
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What is the Dogs of the Dow Strategy? Overview and Examples
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.